Insider Shareholders with Direct Ownership of Structure Therapeutics Inc. (GPCR)
This section provides a comprehensive overview of the insiders with direct ownership of Structure Therapeutics Inc. (GPCR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Structure Therapeutics Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Jun Yoon
CHIEF FINANCIAL OFFICER |
59,469 | 0 | 1,123,133 | 1 |
Mar 15, 2024
Added 5.03%
|
|
Raymond C Stevens
CHIEF EXECUTIVE OFFICER |
284,682 | 555,000 | 793,346 | 3 |
Jun 12, 2024
Added 5.93%
|
|
Crespo Blas Coll
Chief Medical Officer |
90,600 | 0 | 102,600 | 1 |
Sep 18, 2024
Added 46.89%
|
|
Xichen Lin
CHIEF SCIENTIFIC OFFICER |
191,907 | 106,200 | 85,707 | 3 |
Jun 03, 2024
Reduced 55.34%
|
|
Ashley Hall
Chief Development Officer |
67,290 | 0 | 67,290 | 1 |
Sep 18, 2024
Added 50.0%
|
|
Yingli Ma
CHIEF TECHNOLOGY OFFICER |
36,729 | 0 | 36,729 | 1 |
Mar 15, 2024
Added 50.0%
|
|
Mark Allen Bach
CHIEF MEDICAL OFFICER |
26,235 | 0 | 26,235 | 1 |
Mar 15, 2024
Added 50.0%
|
|
Bvf Partners L P
> 10% Shareholder |
0 | 7,410,518 | 0 | 1 |
May 10, 2023
Reduced 100.0%
|